Clinical Trial Update: Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids [Phase 4]

View source ↗

Summary

Open-label comparative Phase 4 trial in de novo renal allograft recipients comparing CSA+MMF+corticosteroids versus CSA+Rapamune+corticosteroids; completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Disease
• Renal Transplant Rejection Prevention

Drugs mentioned

• CSA (cyclosporine) (cyclosporine)
• Corticosteroids (corticosteroids)
• MMF (mycophenolate mofetil) (mycophenolate mofetil)
• Rapamune (sirolimus)

Snippet

Sponsor: Pfizer | Conditions: Inflammation | Phase 4 | Status: COMPLETED | Results posted: 2013-06-19